NCT04789980View on ClinicalTrials.gov

Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY

CompletedOBSERVATIONAL
Enrollment

799

Participants

Timeline

Start Date

January 29, 2021

Primary Completion Date

June 24, 2025

Study Completion Date

June 24, 2025

Conditions
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Trial Locations (1)

Unknown

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY